In the future, 3D bioprinting technology will grow rapidly and generate revenue

According to a commenting article published by the famous investment website Seekingalpha named Cris Frangold, 3D printing technology has become one of the most popular new technologies at present. Among them, the development potential of 3D bioprinting technology is very huge. In a few years, it will achieve rapid growth and generate a lot of income.

Organovo Holdings, a developer and manufacturer of 3D human tissue for medical research and medical devices, is working with cloud design and technology software maker Autodesk to develop the first bioprinting 3D design software.

This software will be used in conjunction with Organovo ’s NovoGen MMX bioprinter, which shows that humans have taken an important step forward in improving the usability and functionality of 3D human tissue design, potentially expanding the number of bioprinting users. Organovo's 3D bioprinting technology can create 3D human tissues, structurally correct and constitute human cells. The tissue created in this way can function like native human tissue, which also provides opportunities for advanced drug discovery and development. It may also be used in clinical treatment and tissue transplantation in the future.

Autodesk is committed to developing the most advanced technologies such as human-computer interaction, computer graphics and digital design. It intends to extend its technology to software development for the design and simulation of molecular and human systems.

What is 3D bioprinting?

Organovo is exploring new ways to print human tissue using materials that can produce body components and to use computerized adaptive manufacturing processes to transplant human tissue. Custom samples and finished products are produced using inexpensive 3D computer printers. These medical printers do not use extruded plastic, metal or ceramic materials, but use living cell materials. This process is called rapid bioprinting. It is an innovative application of the standard technology used in traditional inkjet printers that we are familiar with. These printers can create tissue structures of any shape, such as blood vessels, small pieces of skin and muscles, etc.

Synergy between Organovo and Autodesk

The two companies have great potential for cooperation. Organovo's NovoGen MMX Bioprinter is a brand new, fully automated (custom graphical user interface) software and hardware platform developed specifically to meet the various needs of biological research and bioprinting. From a hardware perspective, it is a powerful tool that uses the latest technology, but it runs on top of the latest software platform. Every time scientists want to use a printer, they must write relevant software from scratch, which means that scientists spend a lot of time debugging software instead of conducting technical research.

Autodesk has become a leader in many specialized design fields. All products that may have been developed in the past 20 years have been developed using Autodesk software, but this will be the first time it has developed something that can create living things. software. The first application to be implemented in the next 5 years is likely to be a simple organization ready for clinical trials. At the same time, Organovo hopes to obtain a stable and sustainable source of income by producing living tissue that can be used for drug research, discovery and development.

The development potential of 3D bioprinting technology

The best way to understand the development potential of 3D bioprinting technology is to compare the evolution of other technologies, which may be completely unimaginable 20 years ago. Although the technology is different, it can still explain the problem. For example, the most typical example is the development of tablet computers and smartphones. The main driving force behind the development of tablet and smartphone technology may be that consumers need a versatile, inexpensive, and practical portable device. Microsoft first launched the Microsoft Tablet PC in 2002, but it did not achieve the success Microsoft had hoped for. Eight years later, Apple launched the iPad in 2010, which broke the technical barriers. Today, tablet PCs are selling well in the global market, and it is expected that its sales will soon exceed notebook PCs.

The development of 3D printing technology has become one of the most popular new technologies today. 3D printing technology can be traced back to 1984. This technology continues to move forward in accordance with Moore's Law, while costs continue to decline, gradually reducing to the point where mainstream companies can use 3D printers. In the past 2 years, the market leaders in 3D printing, 3D Systems and Stratasys, have been the two hottest companies. 3D printing companies have been developing rapidly in recent years. 3D printers are expected to be the hottest topic at the CES show in Las Vegas in early January of this year. 3D Systems stock has risen 15% since the beginning of this year.

BOPP Pearlized Film

Application


1) Books and magazines, pictures, promotional materials;

    non-drying, adhesive, paper bag, clothes lag, liquor, food,cosmetic, medicine, wrapping box

2) Blueprint document, outdoor advertisement, spray paintings, post,digital print.

3) Wedding photograph, photo album

4)Icecream bag,sopa,mask


 Features:

1) Non-solvent adhesive, corona treated good ink adhesion  

2) Superior finish and gloss

3) Environmentally-friendly

4) Convenient Sanitary
5) ROSH

 



Bopp Pearlized Film

Chopsticks Packaging Film,Pearlized Film For Mask,High Smooth Film,Bopp Pearlized Film

Shijiazhuang dadao Packaging materials Co , https://www.ddplasticfilm.com

Posted on